Tag: PFA
Boston Scientific launches NAVIGATE-PF study
Boston Scientific has initiated the NAVIGATE-PF study of the Faraview software module when it is used to visualise and track the Farawave Nav pulsed...
Biosense Webster submits premarket approval application to US FDA for Varipulse...
Biosense Webster has submitted a premarket approval application (PMA) to the US Food & Drug Administration (FDA) for its Varipulse platform. The submission was...
“Second-generation” PFA catheter developer Field Medical closes seed round
Field Medical has closed its oversubscribed seed round with investments totalling US$14million.
The convertible note funding was led by private investors who were joined by...
ADVERTORIAL: Pulsed field ablation: A new frontier in the treatment of...
This article was sponsored by Biosense Webster
According to data published by Patrick M McCarthy (Feinberg School of Medicine, Chicago, USA) and colleagues in the...
HRS 2023: Late-breaking clinical trial results support PFA as treatment option...
New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
First patients treated in Kardium PULSAR IDE study of Globe pulsed...
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
AF Symposium hears late-breaking data from RFA and PFA trials
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy
Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...
Study reveals low reconnection rate with large antral lesion at PW...
A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...